These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9323717)

  • 21. Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques.
    Cho GY; Bolo K; Park KS; Sengillo JD; Tsang SH
    Mol Diagn Ther; 2019 Feb; 23(1):113-120. PubMed ID: 30569401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution in vivo imaging of the RPE mosaic in eyes with retinal disease.
    Roorda A; Zhang Y; Duncan JL
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2297-303. PubMed ID: 17460294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging therapies for inherited retinal degeneration.
    Scholl HP; Strauss RW; Singh MS; Dalkara D; Roska B; Picaud S; Sahel JA
    Sci Transl Med; 2016 Dec; 8(368):368rv6. PubMed ID: 27928030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Future Looks Brighter After 25 Years of Retinal Gene Therapy.
    Auricchio A; Smith AJ; Ali RR
    Hum Gene Ther; 2017 Nov; 28(11):982-987. PubMed ID: 28825330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
    Flannery JG; Visel M
    Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited retinal degenerations: therapeutic prospects.
    Delyfer MN; Léveillard T; Mohand-Saïd S; Hicks D; Picaud S; Sahel JA
    Biol Cell; 2004 May; 96(4):261-9. PubMed ID: 15145530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripherin and the vision thing.
    Davies K
    Nature; 1993 Mar; 362(6415):92. PubMed ID: 8446174
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene therapy for inherited retinal degeneration.
    Ali RR; Reichel MB; Hunt DM; Bhattacharya SS
    Br J Ophthalmol; 1997 Sep; 81(9):795-801. PubMed ID: 9422936
    [No Abstract]   [Full Text] [Related]  

  • 29. Early and late stage gene therapy interventions for inherited retinal degenerations.
    Botto C; Rucli M; Tekinsoy MD; Pulman J; Sahel JA; Dalkara D
    Prog Retin Eye Res; 2022 Jan; 86():100975. PubMed ID: 34058340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic avenues for hereditary forms of retinal blindness.
    Kannabiran C; Mariappan I
    J Genet; 2018 Mar; 97(1):341-352. PubMed ID: 29666355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common microRNA signature in mouse models of retinal degeneration.
    Loscher CJ; Hokamp K; Wilson JH; Li T; Humphries P; Farrar GJ; Palfi A
    Exp Eye Res; 2008 Dec; 87(6):529-34. PubMed ID: 18834879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.
    Wiley LA; Burnight ER; Drack AV; Banach BB; Ochoa D; Cranston CM; Madumba RA; East JS; Mullins RF; Stone EM; Tucker BA
    Hum Gene Ther; 2016 Oct; 27(10):835-846. PubMed ID: 27400765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On Retinal Gene Therapy.
    Fischer MD
    Ophthalmologica; 2016; 236(1):1-7. PubMed ID: 27119148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenoviral-mediated gene transfer to retinal explants during development and degeneration.
    Pang J; Cheng M; Stevenson D; Trousdale MD; Dorey CK; Blanks JC
    Exp Eye Res; 2004 Aug; 79(2):189-201. PubMed ID: 15325566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent breakthroughs in gene therapy for inherited retinal degeneration.
    Revere KE; Chung DC
    Discov Med; 2009 Oct; 8(42):125-9. PubMed ID: 19833058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Name dropping.
    Travis GH
    Nature; 1991 Jan; 349(6304):24. PubMed ID: 1985259
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa.
    Nour M; Fliesler SJ; Naash MI
    Adv Exp Med Biol; 2008; 613():129-38. PubMed ID: 18188937
    [No Abstract]   [Full Text] [Related]  

  • 38. Limited time window for retinal gene therapy in a preclinical model of ciliopathy.
    Datta P; Ruffcorn A; Seo S
    Hum Mol Genet; 2020 Aug; 29(14):2337-2352. PubMed ID: 32568387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for inherited retinal degenerations: initial successes and future challenges.
    Gupta PR; Huckfeldt RM
    J Neural Eng; 2017 Oct; 14(5):051002. PubMed ID: 28829759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal degenerations: planning for the future.
    Berson EL
    Adv Exp Med Biol; 2008; 613():21-35. PubMed ID: 18188925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.